The autonomous notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells

An Ming Wang, Hung Hai Ku, Yu Chih Liang, Yen Chou Chen, Yuh Ming Hwu, Tian-Shun Tsai

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

The Notch signaling pathway plays important roles in a variety of cellular processes. Aberrant transduction of Notch signaling contributes to many diseases and cancers in humans. The Notch receptor intracellular domain, the activated form of Notch receptor, is extremely difficult to detect in normal cells. However, it can activate signaling at very low protein concentration to elicit its biological effects. In the present study, a cell based luciferase reporter gene assay was established in K562 cells to screen drugs which could modulate the endogenous CBF1-dependent Notch signal pathway. Using this system, we found that the luciferase activity of CBF1-dependent reporter gene was activated by baicalin and baicalein but suppressed by niclosamide in both dose- and time-dependent manners. Treatment with these drugs modulated endogenous Notch signaling and affected mRNA expression levels of Notch1 receptor and Notch target genes in K562 cells. Additionally, erythroid differentiation of K562 cells was suppressed by baicalin and baicalein yet was promoted by niclosamide. Colony-forming ability in soft agar was decreased after treatment with baicalin and baicalein, but was not affected in the presence of niclosamide. Thus, modulation of Notch signaling after treatment with any of these three drugs may affect tumorigenesis of K562 cells suggesting that these drugs may have therapeutic potential for those tumors associated with Notch signaling. Taken together, this system could be beneficial for screening of drugs with potential to treat Notch signal pathway-associated diseases.

Original languageEnglish
Pages (from-to)682-692
Number of pages11
JournalJournal of Cellular Biochemistry
Volume106
Issue number4
DOIs
Publication statusPublished - Mar 1 2009

Fingerprint

Niclosamide
K562 Cells
Signal Transduction
Notch Receptors
Luciferases
Reporter Genes
Pharmaceutical Preparations
Notch1 Receptor
Genes
Preclinical Drug Evaluations
Agar
Neoplasms
Carcinogenesis
Messenger RNA
baicalin
baicalein
Tumors
Assays
Screening
Modulation

Keywords

  • Baicalein
  • Baicalin
  • CBF1
  • Niclosamide
  • Notch

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

The autonomous notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells. / Wang, An Ming; Ku, Hung Hai; Liang, Yu Chih; Chen, Yen Chou; Hwu, Yuh Ming; Tsai, Tian-Shun.

In: Journal of Cellular Biochemistry, Vol. 106, No. 4, 01.03.2009, p. 682-692.

Research output: Contribution to journalArticle

@article{61e03c99b3ef4f938643548fc7a94965,
title = "The autonomous notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells",
abstract = "The Notch signaling pathway plays important roles in a variety of cellular processes. Aberrant transduction of Notch signaling contributes to many diseases and cancers in humans. The Notch receptor intracellular domain, the activated form of Notch receptor, is extremely difficult to detect in normal cells. However, it can activate signaling at very low protein concentration to elicit its biological effects. In the present study, a cell based luciferase reporter gene assay was established in K562 cells to screen drugs which could modulate the endogenous CBF1-dependent Notch signal pathway. Using this system, we found that the luciferase activity of CBF1-dependent reporter gene was activated by baicalin and baicalein but suppressed by niclosamide in both dose- and time-dependent manners. Treatment with these drugs modulated endogenous Notch signaling and affected mRNA expression levels of Notch1 receptor and Notch target genes in K562 cells. Additionally, erythroid differentiation of K562 cells was suppressed by baicalin and baicalein yet was promoted by niclosamide. Colony-forming ability in soft agar was decreased after treatment with baicalin and baicalein, but was not affected in the presence of niclosamide. Thus, modulation of Notch signaling after treatment with any of these three drugs may affect tumorigenesis of K562 cells suggesting that these drugs may have therapeutic potential for those tumors associated with Notch signaling. Taken together, this system could be beneficial for screening of drugs with potential to treat Notch signal pathway-associated diseases.",
keywords = "Baicalein, Baicalin, CBF1, Niclosamide, Notch",
author = "Wang, {An Ming} and Ku, {Hung Hai} and Liang, {Yu Chih} and Chen, {Yen Chou} and Hwu, {Yuh Ming} and Tian-Shun Tsai",
year = "2009",
month = "3",
day = "1",
doi = "10.1002/jcb.22065",
language = "English",
volume = "106",
pages = "682--692",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - The autonomous notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells

AU - Wang, An Ming

AU - Ku, Hung Hai

AU - Liang, Yu Chih

AU - Chen, Yen Chou

AU - Hwu, Yuh Ming

AU - Tsai, Tian-Shun

PY - 2009/3/1

Y1 - 2009/3/1

N2 - The Notch signaling pathway plays important roles in a variety of cellular processes. Aberrant transduction of Notch signaling contributes to many diseases and cancers in humans. The Notch receptor intracellular domain, the activated form of Notch receptor, is extremely difficult to detect in normal cells. However, it can activate signaling at very low protein concentration to elicit its biological effects. In the present study, a cell based luciferase reporter gene assay was established in K562 cells to screen drugs which could modulate the endogenous CBF1-dependent Notch signal pathway. Using this system, we found that the luciferase activity of CBF1-dependent reporter gene was activated by baicalin and baicalein but suppressed by niclosamide in both dose- and time-dependent manners. Treatment with these drugs modulated endogenous Notch signaling and affected mRNA expression levels of Notch1 receptor and Notch target genes in K562 cells. Additionally, erythroid differentiation of K562 cells was suppressed by baicalin and baicalein yet was promoted by niclosamide. Colony-forming ability in soft agar was decreased after treatment with baicalin and baicalein, but was not affected in the presence of niclosamide. Thus, modulation of Notch signaling after treatment with any of these three drugs may affect tumorigenesis of K562 cells suggesting that these drugs may have therapeutic potential for those tumors associated with Notch signaling. Taken together, this system could be beneficial for screening of drugs with potential to treat Notch signal pathway-associated diseases.

AB - The Notch signaling pathway plays important roles in a variety of cellular processes. Aberrant transduction of Notch signaling contributes to many diseases and cancers in humans. The Notch receptor intracellular domain, the activated form of Notch receptor, is extremely difficult to detect in normal cells. However, it can activate signaling at very low protein concentration to elicit its biological effects. In the present study, a cell based luciferase reporter gene assay was established in K562 cells to screen drugs which could modulate the endogenous CBF1-dependent Notch signal pathway. Using this system, we found that the luciferase activity of CBF1-dependent reporter gene was activated by baicalin and baicalein but suppressed by niclosamide in both dose- and time-dependent manners. Treatment with these drugs modulated endogenous Notch signaling and affected mRNA expression levels of Notch1 receptor and Notch target genes in K562 cells. Additionally, erythroid differentiation of K562 cells was suppressed by baicalin and baicalein yet was promoted by niclosamide. Colony-forming ability in soft agar was decreased after treatment with baicalin and baicalein, but was not affected in the presence of niclosamide. Thus, modulation of Notch signaling after treatment with any of these three drugs may affect tumorigenesis of K562 cells suggesting that these drugs may have therapeutic potential for those tumors associated with Notch signaling. Taken together, this system could be beneficial for screening of drugs with potential to treat Notch signal pathway-associated diseases.

KW - Baicalein

KW - Baicalin

KW - CBF1

KW - Niclosamide

KW - Notch

UR - http://www.scopus.com/inward/record.url?scp=62649143218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62649143218&partnerID=8YFLogxK

U2 - 10.1002/jcb.22065

DO - 10.1002/jcb.22065

M3 - Article

C2 - 19160421

AN - SCOPUS:62649143218

VL - 106

SP - 682

EP - 692

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 4

ER -